These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11384657)

  • 1. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report.
    Abramov Y; Fatum M; Abrahamov D; Schenker JG
    Fertil Steril; 2001 Jun; 75(6):1228-30. PubMed ID: 11384657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome.
    Fluker MR; Copeland JE; Yuzpe AA
    Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome.
    Chen CD; Yang JH; Chao KH; Chen SU; Ho HN; Yang YS
    Hum Reprod; 1998 Aug; 13(8):2077-81. PubMed ID: 9756272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hydroxyethyl starch and haemaccel for the treatment of severe ovarian hyperstimulation syndrome.
    Gamzu R; Almog B; Levin Y; Avni A; Lessing JB; Baram A
    Fertil Steril; 2002 Jun; 77(6):1302-3. PubMed ID: 12057749
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
    Youssef MA; Al-Inany HG; Evers JL; Aboulghar M
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001302. PubMed ID: 21328249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome.
    Levin I; Almog B; Avni A; Baram A; Lessing JB; Gamzu R
    Fertil Steril; 2002 May; 77(5):986-8. PubMed ID: 12009355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of severe ovarian hyperstimulation in a healthy oocyte donor.
    Halme J; Toma SK; Talbert LM
    Fertil Steril; 1995 Oct; 64(4):857-9. PubMed ID: 7672162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.
    Csokmay JM; Yauger BJ; Henne MB; Armstrong AY; Queenan JT; Segars JH
    Fertil Steril; 2010 Jan; 93(1):167-73. PubMed ID: 18990389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.
    Shoham Z; Weissman A; Barash A; Borenstein R; Schachter M; Insler V
    Fertil Steril; 1994 Jul; 62(1):137-42. PubMed ID: 8005278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study.
    Bellver J; Muñoz EA; Ballesteros A; Soares SR; Bosch E; Simón C; Pellicer A; Remohí J
    Hum Reprod; 2003 Nov; 18(11):2283-8. PubMed ID: 14585874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective analysis of treatment for severe ovary hyperstimulation syndrome complicated by pleural effusion and ascites].
    Gong F; Guo H; Shen Y; Li J; Lu G; Lin G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):720-4. PubMed ID: 22886212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin.
    Orvieto R; Dekel A; Dicker D; Bar-Hava I; Ben-Rafael Z
    Fertil Steril; 1995 Oct; 64(4):860-2. PubMed ID: 7545592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome.
    Chan CC; Yin CS; Lan SC; Chen IC; Wu GJ
    J Chin Med Assoc; 2004 Apr; 67(4):197-9. PubMed ID: 15244020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing and management of iatrogenic moderate and severe ovarian hyperstymulation syndrome (OHSS) in clinical material.
    Jakimiuk AJ; Fritz A; Grzybowski W; Walecka I; Lewandowski P
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S105-8. PubMed ID: 18292845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion.
    Endo T; Kitajima Y; Hayashi T; Fujii M; Hata H; Azumaguchi A
    Fertil Steril; 2004 Nov; 82(5):1449-51. PubMed ID: 15533378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer.
    Mukherjee T; Copperman AB; Sandler B; Bustillo M; Grunfeld L
    Fertil Steril; 1995 Sep; 64(3):641-3. PubMed ID: 7641923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin].
    Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A
    Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.